Home › Psoriatic Arthritis
Psoriatic Arthritis clinical trials recruiting in the U.S.
23 studies for Psoriatic Arthritis are recruiting participants at sites across the United States.
Psoriasis is a skin disease that causes itchy or sore patches of thick, red skin with silvery scales. Find out about symptoms and treatment.
Cities with the most studies
- Houston, TX5 studies
- Durham, NC4 studies
- Milwaukee, WI4 studies
- New York City, NY4 studies
- Dallas, TX3 studies
- Washington, DC3 studies
- Boston, MA3 studies
- San Diego, CA3 studies
- Columbus, OH3 studies
- Charlotte, NC3 studies
- Orlando, FL3 studies
- Philadelphia, PA3 studies
- Cleveland, OH3 studies
- Indianapolis, IN3 studies
- Chicago, IL3 studies
- Altoona, PA3 studies
- Huntington Beach, CA3 studies
By state
- Arizona3 studies
- California9 studies
- Colorado3 studies
- Connecticut3 studies
- District of Columbia3 studies
- Florida7 studies
- Illinois3 studies
- Indiana3 studies
- Massachusetts3 studies
- Michigan3 studies
- New Jersey3 studies
- New York4 studies
- North Carolina6 studies
- Ohio9 studies
- Pennsylvania6 studies
- Tennessee5 studies
- Texas10 studies
- Wisconsin4 studies
Recently updated studies
Continuation Study of Zasocitinib in Adults With Psoriatic Arthritis
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 12, 2026 · NCT07286058Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors
RecruitingObservational study
Ages 18 and older · All sexes · Updated Nov 12, 2026 · NCT04751396Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Nov 12, 2026 · NCT03816345A Study to Assess the Efficacy, Safety and Tolerability of DDY391 in Participants With Moderate to Severe Psoriatic Arthritis
RecruitingPhase 2
Ages 18 to 100 · All sexes · Updated Nov 9, 2026 · NCT07801495Study of Targeted Therapies for the Treatment of Adult Participants With Active Psoriatic Arthritis
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Nov 9, 2026 · NCT06865105A Study to Learn if Bimekizumab Given in Different Ways is Safe and Moves Similarly Throughout the Body Over Time in Adults
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Nov 6, 2026 · NCT07290036Impact of Glucagon-like Peptide-1 (GLP-1) Analogs on Disease Outcomes in Psoriatic Arthritis: A Pragmatic Randomized Controlled Trial
RecruitingPhase 4
Ages 18 and older · All sexes · Updated Nov 5, 2026 · NCT07111494A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
RecruitingPhase 3
Ages 3 and older · All sexes · Updated Nov 3, 2026 · NCT06663332A Remotely Conducted Study to Assess Concentration of TREMFYA in Breast Milk of Lactating Women Who Are Receiving TREMFYA Therapeutically
RecruitingPhase 4
Ages 18 and older · Women · Updated Nov 3, 2026 · NCT07654751Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry
RecruitingObservational study
Up to age 21 · All sexes · Updated Oct 21, 2026 · NCT02418442A Study to Assess the Concentration of Bimekizumab in Mature Breast Milk From Mothers Receiving Treatment With Bimzelx® (Bimekizumab)
RecruitingPhase 1
Ages 18 and older · Women · Updated Sep 18, 2026 · NCT06888193Deucravacitinib-TNFi Combination Therapy for Difficult-to-Control Psoriatic Disease
RecruitingPhase 4
Ages 18 to 65 · All sexes · Updated Sep 1, 2026 · NCT07280702A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or Adalimumab
RecruitingPhase 3
Ages 5 to 17 · All sexes · Updated Sep 1, 2026 · NCT06100744Creating Health Course Study for People With Rheumatological Conditions and Mood Disorders
Recruiting
Ages 18 to 100 · All sexes · Updated Aug 10, 2026 · NCT07180537Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder Arthroplasty
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Jul 9, 2026 · NCT07138898Elucidating Shared Mechanisms Contributing to NAFLD and PsA Disease Severity With Guselkumab Therapy
Recruiting
All ages · All sexes · Updated Jun 10, 2026 · NCT06586281A Study to Evaluate the Impact of Upadacitinib on Spondyloarthritis Outcomes in Patients With Active Psoriatic Arthritis
RecruitingPhase 4
Ages 18 and older · All sexes · Updated Apr 3, 2026 · NCT06454188Rheumatology Patient Registry and Biorepository
RecruitingObservational studyHealthy volunteers welcome
Ages 18 to 99 · All sexes · Updated Feb 13, 2026 · NCT04402086Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research
RecruitingObservational studyHealthy volunteers welcome
Ages 2 and older · All sexes · Updated Jan 22, 2026 · NCT04806620Study to Evaluate Pregnancy Outcomes in Risankizumab Exposed Pregnancies Relative to Those Non-risankizumab Exposed Pregnancies in Women With FDA Approved Indications
RecruitingObservational study
All ages · Women · Updated Jul 17, 2025 · NCT04846959Stelara and Tremfya Pregnancy Exposure Registry OTIS Autoimmune Diseases in Pregnancy Project
RecruitingObservational study
All ages · Women · Updated Jan 28, 2025 · NCT02103361Rheumatology Diet Study
RecruitingObservational study
Ages 18 to 65 · All sexes · Updated Dec 6, 2024 · NCT06339957IMPACT - AndHealth Autoimmune Research Registry
RecruitingObservational study
Ages 18 to 70 · All sexes · Updated Jun 29, 2023 · NCT05883371From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.